Altimmune Inc.

NASDAQ: ALT · Real-Time Price · USD
3.54
0.01 (0.28%)
At close: Aug 22, 2025, 3:59 PM
3.53
-0.28%
After-hours: Aug 22, 2025, 07:53 PM EDT

Altimmune Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
20K 426K -68K 4.41M
Cost of Revenue
n/a 477K 500K 73.84M
Gross Profit
20K -51K -568K -69.43M
Operating Income
-103.17M -95.93M -87.74M -96.91M
Interest Income
8.07M 7.35M 2.87M 203K
Pretax Income
-95.06M -88.45M -84.91M -97.09M
Net Income
-95.06M -88.45M -84.71M -97.09M
Selling & General & Admin
20.97M 18.14M 17.13M 15.41M
Research & Development
82.23M 65.8M 70.54M 74.54M
Other Expenses
n/a -53.38M -70.45M -62.47M
Operating Expenses
103.19M 30.56M 17.22M 27.48M
Interest Expense
9K 35K 8K 5K
Selling & Marketing Expenses
n/a n/a n/a 282.00
Cost & Expenses
103.19M 96.36M 87.67M 101.32M
Income Tax Expense
n/a n/a -197K -919.51K
Shares Outstanding (Basic)
71M 53.25M 46.93M 41.28M
Shares Outstanding (Diluted)
71M 53.25M 46.93M 41.28M
EPS (Basic)
-1.34 -1.66 -1.81 -2.35
EPS (Diluted)
-1.34 -1.66 -1.81 -2.35
EBITDA
-94.81M -87.94M -84.4M -96.53M
EBIT
-95.05M -88.41M -84.9M -97.08M
Depreciation & Amortization
238K 477K 500K 551K